For DKD-related markers, both the insulin and GLP-1RA groups showed significant reductions in the urinary albumin-to-creatinine ratio (UACR) after treatment (p < 0.001 for both), whereas no significant change was observed in the control group. This evidence concerns the gene ALB and diabetic kidney disease.